unknown
Stage
2020
Founded
1
Investors
About
Centessa Pharmaceuticals is a UK-based biotechnology company that discovers and develops medicines. Its pipeline includes orexin receptor 2 (OX2R) agonists for sleep-wake disorders (such as narcolepsy and idiopathic hypersomnia) and a proprietary LockBody antibody technology aimed at cancer therapies.
Explore Centessa Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.